2021
DOI: 10.1016/j.ejphar.2021.174451
|View full text |Cite
|
Sign up to set email alerts
|

Acetyl-CoA carboxylase 2 inhibition reduces skeletal muscle bioactive lipid content and attenuates progression of type 2 diabetes in Zucker diabetic fatty rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 39 publications
0
1
0
Order By: Relevance
“…Evidence suggests that intracellular lipid accumulation in skeletal muscle and decreased lipid oxidation is associated with decreased insulin sensitivity [67]. Indeed, 10-week-old male ZDF rats exhibit higher acyl-CoA and bioactive lipid content in skeletal muscle compared to Sprague-Dawley rat controls [68]. The inhibition of Acetyl-CoA Carboxylase 2 (ACC2), a negative regulator of fatty acid oxidation, decreased acyl-CoA and diacylglycerol accumulation and improved hyperinsulinemia, hyperglycemia, and whole-body insulin resistance [68].…”
Section: Zucker Diabetic Fatty (Zdf/drt-fa) Ratmentioning
confidence: 99%
“…Evidence suggests that intracellular lipid accumulation in skeletal muscle and decreased lipid oxidation is associated with decreased insulin sensitivity [67]. Indeed, 10-week-old male ZDF rats exhibit higher acyl-CoA and bioactive lipid content in skeletal muscle compared to Sprague-Dawley rat controls [68]. The inhibition of Acetyl-CoA Carboxylase 2 (ACC2), a negative regulator of fatty acid oxidation, decreased acyl-CoA and diacylglycerol accumulation and improved hyperinsulinemia, hyperglycemia, and whole-body insulin resistance [68].…”
Section: Zucker Diabetic Fatty (Zdf/drt-fa) Ratmentioning
confidence: 99%